News | Breast Density | December 22, 2022

Careful crafting of the notification language is key to ensuring desired outcomes and minimizing any unintended outcomes

Careful crafting of the notification language is key to ensuring desired outcomes and minimizing any unintended outcomes

December 22, 2022 — You are among the women who dutifully gets an annual mammogram. Year after year, the results are ‘normal.’ But after one mammogram you are shocked to feel a breast lump, which turns out to be cancer. The tumor was hidden behind dense breast tissue so the radiologist couldn’t see it and you wish you had known you were among the nearly 50 percent of women with dense breasts to whom this might happen.

It was this experience that motivated activists to lobby for the breast density notifications that now accompany mammogram results and inform women about the risks of breast density in the 38 U.S. states and the District of Columbia where they are required. The U.S. Food and Drug Administration (FDA) is now preparing language for a nationwide density notification with the goal of informing women and encouraging them to consult their doctors about their personal risk and the potential benefits (and harms) of undergoing supplemental screening.

In a Viewpoint in this week’s JAMA, a researcher from Boston University Chobanian & Avedisian School of Medicine urges the FDA to communicate that warning in language all women can understand to ensure that outcomes are equitable.

“When the FDA crafts this public health message, it needs to be extremely cautious to ensure that all women, and especially women of color or those with low health literacy, understand the message and that the message leads to desired outcomes of appropriate supplemental screening and not to unintended outcomes such as avoidance of future mammograms or receipt of unnecessary additional screening,” says corresponding author Nancy Kressin, PhD, professor of medicine.

Kressin’s research revealed that some states’ and the FDA’s proposed notifications exceeded the general literacy level of women as well as the recommended 8th grade reading level (FDA’s own best practice requirement). They found that knowledge about breast density is not evenly distributed; it is greater among white, more educated women with higher incomes. Some women, especially Latinas, do not always understand the message of the notifications. Less than half of the women they studied understand that breast density also increases the risk of breast cancer.

“After being informed of breast density, Black women and women with less literacy or lower incomes are more likely to report anxiety and confusion. Despite the notifications’ goal of encouraging women to discuss personal risk and the need for supplemental screening with their doctors, few women report such conversations,” says Kressin. 

Kressin recommends that the FDA learn from the more than fifty studies detailing women’s experience with states’ breast density notifications. Additionally, she wants the FDA to use the numerous available tools to test the language of health notifications.

“New density notification language must be rigorously evaluated, like the FDA did for their cigarette warnings, campaigns to reduce youth tobacco use, and promotional materials on the value of generic drugs, to ensure that the wording is clear and understandable to all women, and reactions are those that were intended,” she adds.

Kressin acknowledged this is no small undertaking and that extensive field testing and re-testing will be needed, requiring significant resources. “Yet, evidence indicates that health communications designed to be inclusive of populations with limited literacy or limited English proficiency are preferred by individuals of all literacy levels, so the benefits of doing this work are significant for all women.  We believe such efforts can ensure equitable outcomes across strata of race/ethnicity, education and socioeconomic status.”

For more information: https://www.bumc.bu.edu/

Related Breast Density Content:

AI Provides Accurate Breast Density Classification

VIDEO: The Impact of Breast Density Technology and Legislation

VIDEO: Personalized Breast Screening and Breast Density

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference

Fake News: Having Dense Breast Tissue is No Big Deal

The Manic World of Social Media and Breast Cancer: Gratitude and Grief


Related Content

News | Breast Density

February 6, 2023 — Awareness of breast density appears to increase one’s perceived breast cancer risk for a short time ...

Time February 06, 2023
arrow
News | Radiology Business

February 2, 2023 — Five additional imaging centers across Allegheny Health Network (AHN) have been recognized by the ...

Time February 02, 2023
arrow
News | MRI Breast

February 1, 2023 — Compared to other common supplemental screening methods, breast MRI was superior at detecting breast ...

Time February 01, 2023
arrow
News | Radiation Therapy

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

Time January 31, 2023
arrow
Webinar | Information Technology

Postpandemic staffing shortages and increased volumes require radiologists to do more with less, exacerbating burnout ...

Time January 30, 2023
arrow
News | Stereotactic Breast Imaging

January 27, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), both ...

Time January 27, 2023
arrow
News | Artificial Intelligence

January 26, 2023 — MedCognetics, Inc., an Artificial Intelligence (AI) software firm, announced that it has been awarded ...

Time January 26, 2023
arrow
Feature | Radiology Imaging | By Melinda Taschetta-Millane

Have you read the January/February 2023 issue of Imaging Technology News? If not, take some time out of your busy ...

Time January 24, 2023
arrow
News | Breast Imaging

January 24, 2023 — For patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an ...

Time January 24, 2023
arrow
News | Artificial Intelligence

January 23, 2023 — PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, announced its recent ...

Time January 23, 2023
arrow
Subscribe Now